Social Anxiety Disorder and Specific Phobias
Michelle A. Blackmore
Brigette A. Erwin
Richard G. Heimberg
Leanne Magee
David M. Fresco
Introduction
As our classification systems have been refined, we have come to view social anxiety disorder (social phobia) and specific phobias as distinct disorders, with divergent patterns of prevalence, aetiology, and course. Moreover, treatments for these disorders have become increasingly sophisticated. This chapter presents an overview of the current state of the field with regard to social anxiety disorder and specific phobias.
Social anxiety disorder
In the first and second editions of the Diagnostic and Statistical Manual of Mental Disorders (DSM),(1,2) all phobias were grouped together. However, in 1966 Marks and Gelder(3) observed that various phobias had different ages of onset and symptom presentations, providing the initial impetus for the inclusion of social phobia as a distinct disorder in DSM-III.(4) At first, research into the nature and treatment of social phobia lagged behind that of other anxiety disorders, leading to its description in 1985 as the neglected anxiety disorder.(5) Over the past two decades, however, attention to the conceptualization, definition, and classification of social phobia has increased dramatically. To acknowledge the significant impairment now known to be associated with social phobia and its differentiation from specific phobia, the alternative (and increasingly utilized) label, social anxiety disorder, was added in DSM-IV.(6)
Clinical presentation
Anxiety in situations involving potential evaluation by others (e.g. job interviews, public speaking engagements, first dates) falls within the realm of ‘normal’ social anxiety. For individuals with social anxiety disorder, however, situations such as these are typically associated with incapacitating levels of anxiety and a desire for escape or avoidance. Socially anxious individuals are often self-critical and perfectionistic and go to great lengths to avoid the negative evaluation of others that they may perceive as epidemic. Commonly, persons with social anxiety disorder experience somatic symptoms such as blushing, trembling, dry mouth, or perspiring, which they believe will be noticed by others and provide further evidence of their incompetence. Children may manifest their anxiety differently than adults; they may cry, throw tantrums, freeze, shrink from interactions with strangers, and they may not acknowledge that their fears are irrational.(6) By leaving anxiety-provoking situations (escape) or foregoing them entirely (avoidance), individuals with social anxiety disorder may reduce or prevent the immediate experience of anxiety, but this behaviour reinforces beliefs in their inadequacies and serves to maintain anxiety in the absence of objective threat.(7,8)
Functional impairment
Individuals with social anxiety disorder experience significant impairment in social, educational, and occupational functioning.(5,9) They are less likely to marry and are more likely to divorce than those without the disorder.(10) They also have fewer friends and more trouble getting along with the friends they have than persons without the disorder.(11) Individuals with social anxiety disorder assessed in a primary care setting reported missing an average of 3 days of work and having an average of 6 days of reduced productivity in the last month because of their emotional problems.(12) Comparatively, mentally healthy individuals reported less than 1 day of lost work and reduced productivity combined. Unemployment, underemployment (working at a level below the individual’s abilities), and financial dependency are also characteristic of individuals with social anxiety disorder.(10)
Classification
(a) DSM and ICD
Whereas the DSM is widely used in North America, the International Classification of Mental and Behavioural Disorders (ICD) is commonly used in other parts of the world. Social anxiety disorder, termed social phobia in ICD-10,(13) first appeared in ICD-10 12 years after its appearance in DSM-III. The ICD-10 criteria for social phobia are less detailed and more circumscribed than those in DSM-IV. Specifically, DSM-IV requires excessive fear of humiliation or embarrassment in social or performance situations, anxiety provoked by exposure to feared situations, recognition that the fear is excessive, avoidance of situations or endurance with distress, and significant distress or impairment. Further, the fear and avoidance cannot be better accounted for by another psychiatric disorder, a general medical condition, or the effects of a substance. The ICD-10, in contrast, requires only that the symptoms be representative of anxiety and not another psychiatric disorder, that the anxiety occurs in relation to social situations, and that avoidance of anxiety-provoking situations be present. Because most published research on social anxiety disorder relies on DSM rather than ICD criteria, this chapter will do so also.
(b) Diagnostic issues
Individuals presenting for treatment of social anxiety disorder endorse multiple fears and significant impairment. The generalized subtype is specified when ‘most social situations’ are feared, whereas the non-generalized subtype describes persons who fear a more limited set of social situations. Individuals with generalized and non-generalized social anxiety disorder differ on several dimensions, including symptom severity, functional impairment, and physiological symptoms when exposed to feared situations.(14) Conclusive differences between subtypes in course and response to treatment remain to be demonstrated.(15,16)
Like social anxiety disorder, avoidant personality disorder is regarded as an extreme fear of negative evaluation, leading researchers to view the two conditions on a continuum that is artificially divided at the boundary between Axes I and II. Many investigators conclude that the co-occurrence of generalized social anxiety disorder and avoidant personality disorder represent persons with the most severe social anxiety and the poorest global functioning.(17)
Social anxiety may also develop as a result of medical conditions, such as becoming excessively anxious or avoiding social situations because of obesity, acne, benign essential tremor, stuttering, or the disability associated with Parkinson’s disease. These conditions are not considered exemplars of social anxiety disorder because anxiety developed secondary to the medical condition. Rather, they are assigned to the category ‘anxiety disorder not otherwise specified’. However, persons who experience secondary social anxiety are often responsive to pharmacological or cognitive behavioural treatments with demonstrated efficacy for social anxiety disorder.(18)
(c) Comorbidity and differential diagnosis
Approximately 81 per cent of persons with primary social anxiety disorder meet criteria for at least one other lifetime psychiatric disorder.(19) Social anxiety disorder most commonly co-occurs with other anxiety disorders,(20) although comorbid diagnoses of depression and alcohol use disorders are also common. Differential diagnosis is complicated by the fact that certain Axis I disorders both resemble and co-occur with social anxiety disorder.
(d) Social anxiety disorder versus panic disorder with agoraphobia (PDA)
PDA can be differentiated from social anxiety disorder in several ways. Although many individuals with social anxiety disorder experience panic attacks, the attacks occur in anticipation of negative evaluation by others. For persons with panic disorder, panic attacks are often unexpected, may not be associated with specific cognitions, and can be nocturnal.(5) Persons with social anxiety disorder are more likely to experience blushing and muscle twitches, whereas individuals with PDA are more likely to experience symptoms such as blurred vision, headaches, chest pain, ringing in the ears, and fear that they will die or go crazy.(21) The age of onset for social anxiety disorder tends to be earlier than that for PDA.(22) Individuals presenting for social anxiety disorder treatment either show an equal gender distribution or are slightly more likely to be male,(23) whereas those presenting for PDA treatment are substantially more likely to be female.(21) Finally, persons with social
anxiety disorder report feeling more comfortable when alone, whereas persons with PDA may feel more at ease in the presence of others.(22)
anxiety disorder report feeling more comfortable when alone, whereas persons with PDA may feel more at ease in the presence of others.(22)
(e) Social anxiety disorder versus generalized anxiety disorder (GAD)
Individuals with GAD endorse higher levels of social anxiety than other persons with non-social anxiety disorders.(23) Although individuals with either social anxiety disorder or GAD may devote excessive amounts of time to worrying and ruminating, the focus of worry in social anxiety disorder is on fear of evaluation in social or performance situations, whereas the hallmark feature of worry in GAD is heightened focus on possible catastrophic consequences across several domains of life. Persons with social anxiety disorder are more likely to experience sweating, flushing, and breathing problems; those with GAD more commonly experience headaches, insomnia, and fear of dying.(24)
(f) Social anxiety disorder versus depression
Social anxiety disorder and depression may have withdrawal from social situations in common.(21) In differentiating between the two disorders, one must consider the reason for this withdrawal. Persons with depression withdraw because they fail to experience pleasure or lack the energy for social engagement. Individuals with social anxiety disorder fear the negative evaluation they believe to be associated with such situations. Persons with depression may be indifferent about engaging in social situations, whereas individuals with social anxiety disorder often have a strong desire to affiliate with others that is hampered by anxiety.
Epidemiology
(a) Prevalence
The National Comorbidity Survey Replication (NCS-R) reported a lifetime prevalence rate of 12.1 per cent(25) and a 12-month prevalence rate of 6.8 per cent(20) for social anxiety disorder. NCS-R lifetime prevalence rates render social anxiety disorder the fourth most common psychiatric disorder behind major depression (16.6 per cent), alcohol abuse (13.2 per cent), and specific phobia (12.5 per cent).
(b) Age at onset/age of treatment seeking
Social anxiety disorder often begins early in life. Mean age of onset for the disorder ranges from 13 to 20 years old, although patients often report having experienced symptoms for as long as they can remember.(26) Despite early onset, persons with social anxiety disorder often do not seek treatment for approximately 16 years after onset,(27) and many never do.(28)
(c) Gender differences
Although men and women with social anxiety disorder who seek treatment do so in relatively equal numbers,(23) epidemiological studies suggest that women are more likely than men to have the disorder.(19,25) In a clinical sample, women reported fear of more social situations and scored higher on several social anxiety disorder assessment measures.(29) Thus, although women are more likely to experience social anxiety, men are more likely to seek treatment and may do so when troubled with less severe symptoms. It may be that social anxiety disorder impairs the expected role functioning of men to a greater extent that it does for women.(29)
Aetiology of social anxiety disorder
Genetic factors appear to contribute to the emergence of social anxiety disorder. Higher rates of social anxiety disorder have been found in relatives of individuals with the disorder compared to relatives of persons without the disorder.(30) Further, rates of social anxiety disorder in first-degree relatives of probands with the generalized subtype are higher than in relatives of probands with the non-generalized subtype or with no psychiatric history.(31) Kendler et al.(32) report concordance rates for social anxiety disorder among monozygotic twins (24.4 per cent) to be greater than the rates for dizygotic twins (15.3 per cent). A study conducted with the same cohort 8 years later found the heritability of social anxiety disorder to be approximately 50 per cent in female twins(33) and 25 per cent in male twins.(34)
Neurobiological factors may also be associated with social anxiety disorder. Imaging studies of individuals with social anxiety disorder have demonstrated increased activity in regions associated with fear and anxiety (i.e. prefrontal cortex, amygdala, hippocampus) during anxiety-provoking tasks.(35) Given the efficacy of serotonin reuptake inhibitors and monoamine oxidase inhibitors in treating social anxiety disorder,(36) dysregulation of the serotonin(37) and dopamine(38) systems have been investigated as potential correlates of the disorder.
Several studies also suggest the importance of parental influences and significant life events in the development of social anxiety disorder. Persons with social anxiety recall observing their mothers act more fearful and avoidant of social interactions(39) and describe their parents as overprotective.(40) Stressful social and performance situations early in life (e.g. public ridicule, being bullied, mind going blank during a presentation) are also commonly reported by persons with social anxiety disorder.(41)
Course of social anxiety disorder
Social anxiety disorder is chronic and unlikely to remit without treatment. The disorder persists throughout adulthood(42) and its course is unrelated to gender, age of onset, duration of illness, level of functioning at intake, lifetime history of anxiety disorders, or current comorbidity of anxiety or depressive disorders.(42,43) Two conditions related to social anxiety disorder emerge in childhood and are relatively stable into adulthood—shyness and behavioural inhibition. Individuals who had been shy as children exhibited overall lower levels of functioning when assessed 30 years later.(44) Similarly, children described as behaviourally inhibited, or having the tendency to withdraw from novel people, settings, or objects, have demonstrated increased risk for the development of social anxiety disorder in adolescence.(45) Behavioural inhibition was also more prevalent in children of individuals with anxiety disorders and remained relatively stable for over 7 years in children initially assessed between the ages of 21 to 31 months.(46) These findings suggest that extreme shyness and behavioural inhibition may be early manifestations of social anxiety disorder.
Empirically evaluated treatments
(a) Cognitive behavioural interventions
Cognitive behavioural treatments have been subjected to the most thorough evaluation in the empirical literature. Treatments that utilize exposure alone or combined with cognitive restructuring have received the greatest empirical support and are the focus of
our review. Because of space limitations, other cognitive behavioural treatments, such as social skills training and applied relaxation, will not be reviewed, and the reader is referred to other sources.(47)
our review. Because of space limitations, other cognitive behavioural treatments, such as social skills training and applied relaxation, will not be reviewed, and the reader is referred to other sources.(47)
(b) Exposure
Exposure requires individuals to imagine (imaginal exposure) or directly confront (in vivo exposure) feared stimuli. Research examining the efficacy of imaginal exposure for social anxiety disorder is limited; however, in vivo exposure has repeatedly demonstrated short- and long-term efficacy in therapist-directed and self-directed formats.(47) Exposure requires patients to progressively confront anxiety-provoking situations beginning with situations that elicit moderate fear. Patients turn to the next most feared situation after repeated and prolonged exposure to the previous situation no longer elicits a distressing level of fear. Individuals with social anxiety disorder treated with exposure alone experienced greater improvement than individuals receiving relaxation training,(48) pill placebo,(49) or delayed treatment.(50)
(c) Exposure combined with cognitive restructuring
Contemporary cognitive behavioural models of social anxiety disorder propose that anxiety is largely maintained by dysfunctional beliefs and information-processing biases, and that successful treatment will be associated with modification of cognition.(7,8) Accordingly, exposure is typically combined with techniques designed to modify dysfunctional thinking patterns.(51,52)
Cognitive restructuring is an intervention based on the theory that one’s thoughts about a situation, not the situation itself, generate anxiety.(53) The intervention is designed to help patients challenge maladaptive beliefs by identifying irrational thoughts, evaluating the dysfunction inherent in these thoughts, and deriving rational alternatives to these thoughts. By engaging in this process and utilizing alternative thoughts during exposure to feared situations, patients acquire new, adaptive learning that competes with their previously-learned maladaptive views, and, in turn, lessens the anxiety they experience.(54)
Efficacy for the combination of cognitive restructuring and exposure has been demonstrated in comparison to wait-list control conditions,(55,56) pill placebo,(57) and psychological placebo conditions.(57,58) Several studies demonstrate equivalent outcomes for exposure alone and exposure plus cognitive restructuring, whereas others indicate the combination shows superior efficacy and additional gains at follow-up.(47) In one meta-analysis,(59) only the combination of exposure and cognitive restructuring was superior to placebo treatments, but this difference has not been reliably demonstrated.(60) Nevertheless, patients treated with exposure alone tend to show deterioration of gains after treatment, suggesting durability of gains may be enhanced with the addition of cognitive restructuring techniques.
(d) Cognitive behavioural group therapy (CBGT)
CBGT, originally developed by Heimberg and Becker,(51) is one of the most thoroughly examined cognitive behavioural treatments for social anxiety disorder. It integrates cognitive techniques and exposure and is typically conducted in 12 weekly, 2.5 h sessions, with approximately six patients and two therapists. In sessions 1-2, patients receive psychoeducation, rationale and instructions for exposure, training in cognitive restructuring, and homework assignments. Thereafter, therapists lead patients through individualized exposures preceded and followed by therapist-directed cognitive restructuring exercises. For homework, patients practice cognitive restructuring before and after exposure to real-life anxiety-provoking situations.
One study evaluating the efficacy of CBGT compared it to educational-supportive group therapy (ES), a credible placebo treatment consisting of lectures, discussions, and social support. Seventy-five per cent of CBGT patients made significant improvement compared to 40 per cent of ES patients.(58) At follow-up (4.5-6.25 years), CBGT produced durable treatment gains.(61) A comparison of CBGT to the monoamine oxidase inhibitor phenelzine, pill placebo, and ES demonstrated equivalent response and attrition rates after 12 weeks of treatment for CBGT and phenelzine, both of which were superior to placebo and ES.(57) Although the phenelzine group evidenced superior improvement on a subset of measures after 12 weeks, CBGT demonstrated more durable treatment gains, with only 17 per cent relapse compared to 50 per cent relapse in the phenelzine group after a 6-month maintenance phase and 6-month follow-up phase.(62) An intensive version of CBGT, based on a hybrid of the treatment approaches developed by Heimberg and by Clark, involving 2 weeks of daily treatment sessions separated by 1 week of homework assignments, also proved superior to a wait-list control.(63)
(e) Individual cognitive behavioural therapy
Group CBT may not always be feasible, particularly in clinical settings where it may be difficult to obtain an adequate number of patients to form a group. However, CBGT has been adapted to an individual format and proven superior to a wait-list control (Heimberg, unpublished observations). Clark(52) also developed a cognitively-focused individual treatment for social anxiety disorder that has demonstrated substantial efficacy. The treatment instructs patients on how to shift their attention externally (rather than on the self) and to reduce reliance on safety behaviours. Video feedback and exposure to feared situations aimed at restructuring distorted cognitions are also incorporated.
Individual cognitive therapy demonstrated superior efficacy to wait-list control, with clinically significant gains observed in 76 per cent of patients receiving cognitive therapy, compared to 38 per cent of patients receiving an applied relaxation treatment and 0 per cent of patients in the wait-list control group.(64) Cognitive therapy was also more efficacious than fluoxetine plus self-exposure instructions and placebo plus self-exposure instructions, with gains maintained at 1-year follow-up.(65) Although meta-analytic studies suggest that individual and group CBT are similar in efficacy,(60) individual cognitive therapy was superior to a group therapy based on Clark’s model on several measures.(66) Similarly, individual cognitive therapy proved superior to a 3-week intensive group therapy based on Clark’s model and treatment with psychiatrist-selected SSRIs.(67)

Stay updated, free articles. Join our Telegram channel

Full access? Get Clinical Tree


